STOCK TITAN

Growth Cap Acquisition Corp Stock Price, News & Analysis

GCACU Nasdaq

Welcome to our dedicated page for Growth Cap Acquisition news (Ticker: GCACU), a resource for investors and traders seeking the latest updates and insights on Growth Cap Acquisition stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Growth Cap Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Growth Cap Acquisition's position in the market.

Rhea-AI Summary

Growth Capital Acquisition Corp. (NASDAQ: GCACU) has successfully closed its initial public offering, selling 17,250,000 units at $10.00 each for total gross proceeds of $172.5 million. The offering included 2,250,000 units from the underwriters’ over-allotment option. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with whole warrants exercisable at $11.50 per share. The units began trading on Nasdaq on January 29, 2021, under the symbol GCACU. Maxim Group LLC served as the sole book-running manager.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Growth Capital Acquisition Corp. (NASDAQ: GCACU) has priced its initial public offering (IPO) at $10.00, offering 15,000,000 units consisting of one share of Class A common stock and half a redeemable warrant. Trading on Nasdaq is set to begin on January 29, 2021, under the symbol 'GCACU'. Each whole warrant allows purchase of a Class A share at $11.50. The underwriters hold a 45-day option for an additional 2,250,000 units. The offering is expected to close on February 2, 2021, pending customary closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Growth Cap Acquisition Corp

Nasdaq:GCACU

GCACU Rankings

GCACU Stock Data

17.25M
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link